1966
DOI: 10.1001/archinte.118.6.565
| |Summarize |Cite
|
Sign up to set email alerts

Hydroxyproline excretion in malignant neoplastic disease

Search citation statements

Order By: Relevance

Paper Sections

Select...
23
2
1
0

Citation Types

0
7
0
1

Year Published

Range
1967
1967
2024
2024

Publication Types

Select...
20
4
1

Relationship

0
25

Authors

Journals

Cited by 25 publications

(8 citation statements)

References 24 publications

0
7
0
1
Order By: Relevance
How the paper below cites the one you are viewing
“…The results of this study of 181 consecutive patients with breast carcinoma confirm those reported by others (Rubegni, Ravenni and Del Giovane, 1962;Platt et at., 1964;Bonadonna et at., 1966;Hosley et al, 1966;Guzzo et al, 1969;Cushieri and Felgate, 1972;Summer et al, 1973), that increased hydroxyproline excretion is a sensitive index of the presence of bone metastases.…”
Section: Discussion
mentioning
confidence: 99%
“…Cerda et al (1970) believe that the measurement of urinary hydroxyproline has advantages over procedures like electrophoresis, heat stability and chemical inhibition in characterizing the bone or liver source of an elevated serum alkaline phosphatase. While metastatic liver disease may cause elevations in the serum alkaline phoSphatase, concomitant elevations in the urinary hydroxyproline are usually absent (Hosley et al, 1966).…”
Section: Discussion
mentioning
confidence: 99%
See 1 more Smart Citation